Cited by 1,674Cancer Cells and Metastasis3D Printing in Biomedical ResearchMathematical Biology Tumor Growth

Multicellular tumor spheroids: An underestimated tool is catching up again

Hirschhaeuser, Franziska, Menne, Heike, Dittfeld, Claudia, West, Jonathan, Mueller-Klieser, Wolfgang, Kunz-Schughart, Leoni A.·2010·Journal of Biotechnology

Abstract

The present article highlights the rationale, potential and flexibility of tumor spheroid mono- and cocultures for implementation into state of the art anti-cancer therapy test platforms. Unlike classical monolayer-based models, spheroids strikingly mirror the 3D cellular context and therapeutically relevant pathophysiological gradients of in vivo tumors. Some concepts for standardization and automation of spheroid culturing, monitoring and analysis are discussed, and the challenges to define the most convenient analytical endpoints for therapy testing are outlined. The potential of spheroids to contribute to either the elimination of poor drug candidates at the pre-animal and pre-clinical state or the identification of promising drugs that would fail in classical 2D cell assays is emphasised. Microtechnologies, in the form of micropatterning and microfluidics, are also discussed and offer the exciting prospect of standardized spheroid mass production to tackle high-throughput screening applications within the context of traditional laboratory settings. The extension towards more sophisticated spheroid coculture models which more closely reflect heterologous tumor tissues composed of tumor and various stromal cell types is also covered. Examples are given with particular emphasis on tumor-immune cell cocultures and their usefulness for testing novel immunotherapeutic treatment strategies. Finally, tumor cell heterogeneity and the extraordinary possibilities of putative cancer…

Integrity signals

Registry

Crossref · 10.1016/j.jbiotec.2010.01.012

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A.
Affiliations
  • University Medical Center of the Johannes Gutenberg University Mainz (DE)
  • Leibniz Institute for Analytical Sciences - ISAS (DE)
  • OncoRay (DE)
Venue
Journal of Biotechnology
Publisher
Elsevier BV
Published
2010-07
Volume
148
Issue
1
Pages
3-15
ISSN
0168-1656 (ISSN-L)
OpenAlex
W2136445803
Cited by
1,674
References
5
Citations by year
2026: 71 · 2025: 90 · 2024: 99 · 2023: 96 · 2022: 92 · 2021: 122 · 2020: 129 · 2019: 128 · 2018: 132 · 2017: 138 · 2016: 157 · 2015: 104 · 2014: 119 · 2013: 95 · 2012: 48
FWCI
31.03
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords
tumor spheroids, anticancer drug screening, 3D tumor models, therapeutic endpoints, micropatterning, microfluidics, high-throughput screening, tumor stroma, tumor heterogeneity, cancer stem cells, drug development
MeSH terms
Animals, Drug Evaluation, Preclinical, Humans, Tumor Cells, Cultured, Spheroids, Cellular, Coculture Techniques, Microfluidic Analytical Techniques, Mice, High-Throughput Screening Assays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review